These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38314697)

  • 1. Integrated miRNA-mRNA networks underlie attenuation of chronic β-adrenergic stimulation-induced cardiac remodeling by minocycline.
    Russell JJ; Mummidi S; DeMarco VG; Grisanti LA; Bailey CA; Bender SB; Chandrasekar B
    Physiol Genomics; 2024 Apr; 56(4):360-366. PubMed ID: 38314697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure.
    Karam S; Margaria JP; Bourcier A; Mika D; Varin A; Bedioune I; Lindner M; Bouadjel K; Dessillons M; Gaudin F; Lefebvre F; Mateo P; Lechène P; Gomez S; Domergue V; Robert P; Coquard C; Algalarrondo V; Samuel JL; Michel JB; Charpentier F; Ghigo A; Hirsch E; Fischmeister R; Leroy J; Vandecasteele G
    Circulation; 2020 Jul; 142(2):161-174. PubMed ID: 32264695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsomal Prostaglandin E
    Ji S; Guo R; Wang J; Qian L; Liu M; Xu H; Zhang J; Guan Y; Yang G; Chen L
    J Pharmacol Exp Ther; 2020 Oct; 375(1):40-48. PubMed ID: 32759273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct actions of intermittent and sustained β-adrenoceptor stimulation on cardiac remodeling.
    Ma X; Song Y; Chen C; Fu Y; Shen Q; Li Z; Zhang Y
    Sci China Life Sci; 2011 Jun; 54(6):493-501. PubMed ID: 21706409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic β-adrenergic receptor stimulation.
    Grisanti LA; Repas AA; Talarico JA; Gold JI; Carter RL; Koch WJ; Tilley DG
    Am J Physiol Heart Circ Physiol; 2015 Feb; 308(4):H316-30. PubMed ID: 25485901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Set7 deletion attenuates isoproterenol-induced cardiac fibrosis and delays cardiac dysfunction.
    Lunardon G; de Oliveira Silva T; Lino CA; Lu YW; Miranda JB; Asprino PF; de Almeida Silva A; Nepomuceno GT; Irigoyen MCC; Carneiro-Ramos MS; Takano APC; Martinho HDS; Barreto-Chaves MLM; Wang DZ; Diniz GP
    Clin Sci (Lond); 2022 Nov; 136(21):1537-1554. PubMed ID: 36285636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MIR217HG aggravates pressure-overload induced cardiac remodeling by activating miR-138/THBS1 pathway.
    Nie X; Xie R; Fan J; Wang DW
    Life Sci; 2024 Jan; 336():122290. PubMed ID: 38013141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CaMKIIδ mediates β-adrenergic effects on RyR2 phosphorylation and SR Ca(2+) leak and the pathophysiological response to chronic β-adrenergic stimulation.
    Grimm M; Ling H; Willeford A; Pereira L; Gray CB; Erickson JR; Sarma S; Respress JL; Wehrens XH; Bers DM; Brown JH
    J Mol Cell Cardiol; 2015 Aug; 85():282-91. PubMed ID: 26080362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
    Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA Expression Signature Is Altered in the Cardiac Remodeling Induced by High Fat Diets.
    Guedes EC; França GS; Lino CA; Koyama FC; Moreira Ldo N; Alexandre JG; Barreto-Chaves ML; Galante PA; Diniz GP
    J Cell Physiol; 2016 Aug; 231(8):1771-83. PubMed ID: 26638879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts.
    Matkovich SJ; Wang W; Tu Y; Eschenbacher WH; Dorn LE; Condorelli G; Diwan A; Nerbonne JM; Dorn GW
    Circ Res; 2010 Jan; 106(1):166-75. PubMed ID: 19893015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ATGL in adipose tissue ameliorates isoproterenol-induced cardiac remodeling by reducing adipose tissue inflammation.
    Takahara S; Ferdaoussi M; Srnic N; Maayah ZH; Soni S; Migglautsch AK; Breinbauer R; Kershaw EE; Dyck JRB
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H432-H446. PubMed ID: 33185110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-expression of microRNA-145 drives alterations in β-adrenergic signaling and attenuates cardiac remodeling in heart failure post myocardial infarction.
    Liu Z; Tao B; Fan S; Cui S; Pu Y; Qiu L; Xia H; Xu L
    Aging (Albany NY); 2020 Jun; 12(12):11603-11622. PubMed ID: 32554856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging Impairs Reverse Remodeling and Recovery of Ventricular Function after Isoproterenol-Induced Cardiomyopathy.
    Yáñez-Bisbe L; Garcia-Elias A; Tajes M; Almendros I; Rodríguez-Sinovas A; Inserte J; Ruiz-Meana M; Farré R; Farré N; Benito B
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of β-Adrenoceptors in Isoproterenol-Induced Cardiac Remodeling through HuR.
    Yin Q; Yang C; Wu J; Lu H; Zheng X; Zhang Y; Lv Z; Zheng X; Li Z
    PLoS One; 2016; 11(4):e0152005. PubMed ID: 27035432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined deep microRNA and mRNA sequencing identifies protective transcriptomal signature of enhanced PI3Kα signaling in cardiac hypertrophy.
    Yang KC; Ku YC; Lovett M; Nerbonne JM
    J Mol Cell Cardiol; 2012 Jul; 53(1):101-12. PubMed ID: 22580345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nourin-Associated miRNAs: Novel Inflammatory Monitoring Markers for Cyclocreatine Phosphate Therapy in Heart Failure.
    Elgebaly SA; Todd R; Kreutzer DL; Christenson R; El-Khazragy N; Arafa RK; Rabie MA; Mohamed AF; Ahmed LA; El Sayed NS
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.
    Bernardo BC; Ooi JY; Matsumoto A; Tham YK; Singla S; Kiriazis H; Patterson NL; Sadoshima J; Obad S; Lin RC; McMullen JR
    J Physiol; 2016 Oct; 594(20):5959-5974. PubMed ID: 27270487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of Microfibrillar-Associated Protein 4 Attenuates Left Ventricular Remodeling and Dysfunction in Heart Failure.
    Wang HB; Yang J; Shuai W; Yang J; Liu LB; Xu M; Tang QZ
    J Am Heart Assoc; 2020 Sep; 9(17):e015307. PubMed ID: 32856514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.